Meet Us in Atlanta for AACR

We will be joining thousands of oncology researchers and clinicians this week at the American Association for Cancer Research Annual Meeting, March 29 – April 3 at the Georgia World Congress Center. Stop by our booth #3051 to learn how DNAnexus Apollo enables advanced exploration of cancer datasets for therapeutic target discovery. Our scientific experts will be onsite all week for demos and to answer all your bioinformatics questions.

Last year at AACR, in partnership with St. Jude Children’s Research Hospital and Microsoft, St. Jude Cloud was launched, the largest public repository of pediatric genomic cancer data. Offering a suite of unique analysis tools and visualizations, researchers can efficiently mine, analyze, and visualize next-generation sequencing data for pediatric cancer and other life threatening diseases to accelerate scientific discoveries.

This year, St. Jude Children’s Research Hospital is celebrating the one year anniversary of the St. Jude Cloud and since its inception, 10,000 WGS data have been analyzed in continuation of the search to find a cure for pediatric cancer and other life-threatening diseases. If you want to know more about the St. Jude Cloud, visit their booth #4136. We are excited to celebrate the one year anniversary with St. Jude Children’s Research Hospital and St. Jude Cloud team – how cool is it that we’re back at AACR together?!

Make sure to stop by either DNAnexus booth or the St. Jude Cloud booth, to celebrate with us at AACR! Check out our conference activities below. Can’t make it to any of our events? Request a meeting.

Demo: Explore Millions of Clinico-Genomic Data Points in Seconds with DNAnexus Apollo

  • Monday, April 1st – 1:00pm-2:00pm
  • Tuesday, April 2nd – 10:30am-11:30am

Cancer genomics is advancing precision medicine, leading to better diagnoses and treatment strategies. The Cancer Genome Atlas (TCGA), extensively characterized over 20,000 primary cancer and matched normal samples, creating a deep resource of over 25 petabytes of genomic, epigenomic, transcriptomic, and proteomic data. This landmark program has already lead to improvements in researchers’ ability to diagnose, treat and prevent cancer, yet mining this type of data for novel findings remains a huge endeavor.

DNAnexus Apollo enables at-scale navigation and exploration on combined genotypic and phenotypic data, whether it is TCGA data, your own protected data, or a combination. What actionable information will you find in your cancer datasets?

Customer Poster

3671 / 29 – Visualize 10,000 Whole Genomes from Pediatric Cancer Patients on St. Jude Cloud 

  • April 2nd, 1 – 5pm
  • Presenter: Clay McLeod, St Jude Children’s Research Hospital

Discussing the State of Biomedical Data & Looking Towards the Future at PMWC

DNAnexus once again attended the Precision Medicine World Conference (PMWC) in January in Santa Clara, California, to learn about new innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care.

George Asimenos, Chief Technology Officer, hosted a panel discussing the challenges in applying AI on biomedical data and the future of using AI in regulated contexts. Brady Davis, VP Strategy and Marketing, also moderated a discussion on the future of DNA sequencing interpretation, touching on how visualizations are driving the understanding of human genomes & diseases.

You can view the recorded panel discussions below:

Challenges In Applying AI On Biomedical Data

Challenges in AI Panel

Moderator: George Asimenos, PhD, CTO, DNAnexus

Panelists:

  • University of Washington, Paul G. Allen School of Computer Science & Engineering – Su-In Lee, PhD, Associate Professor
  • UCSF, Helen Diller Family Comprehensive Cancer Center – Laura J. van’t Veer, PhD, Leader, Breast Oncology Program, and Director
  • Regeneron Genetics Center – Jeffrey Reid, PhD, Head of Genome Informatics

Abstract:

AI methods promise to revolutionize the way we approach medicine, by building and training models that make accurate predictions. But the application of AI in actual biomedical contexts comes with distinct challenges. This session features speakers in the forefront of real-life AI applications, who will discuss challenges such as how to reach an interpretable/explainable AI model and how to apply AI in a regulated context.

Data Curation, Integration and Visualization

Data Curation Panel

Moderator: Brady Davis, VP Strategy and Marketing, DNAnexus

Panelists:

  • Stanford University, Department of Genetics – J. Michael Cherry, PhD, Professor
  • AncestryDNA – Eurie Hong, PhD, Senior Director of Genomics
  • UC Santa Cruz Genomics Institute – Benedict Paten, PhD, Assistant Professor

Abstract:

Understanding the relationship between the millions of functional DNA elements and their protein regulators, and how they work in conjunction to manifest diverse phenotypes, is a key to advancing our understanding of the human genome and diseases. As the cost of DNA sequencing continue to drop, the interpretation of the ever increasing amount of data generated represents a considerable challenge.

See our Talk at HiMSS 2019 – Integrating Clinico-Genomic Data for Precision Health

We’ve landed in Orlando and are ready to enjoy our time at the annual HiMSS Global Conference! In addition to 45,000 other healthcare professionals attending, we are taking the full opportunity of the sun to discuss and discover new ways to utilize information and technology to accelerate healthcare insights. Learn more about the HiMSS Conference.

Join us at the Amazon Web Services Booth #5058 where we will be presenting how population-scale data collection initiatives are pioneering new frontiers in precision medicine, while simultaneously bringing about new challenges on integration of diverse datasets and extraction of high-impact insights. Researchers must overcome the complexities of datasets including multi-omic and clinical data securely and at scale.

We will discuss the recently launched DNAnexus Apollo™, a scalable cloud platform, with flexible data models and intuitive analysis & visualization tools that eliminates the complexities many researchers face, enabling integration of big data, driving to actionable insights and rapid discovery. Additional topics covered:

  • Success in powering precision medicine
  • Trends shaping the future of healthcare
  • Showcase multi-omic & clinical data science exploration, analysis, & discovery
  • How cloud-based data analysis and secure collaboration drive scientific discovery
Integrating clinico-genomic data for precision health

Aniket Deshpande, Science Lead

Tuesday, February 12 at 4:30pm

AWS Booth #5058

                   Aniket Deshpande

Leveraging the trusted best-in-class DNAnexus security and privacy framework, including HIPAA, CLIA, GxP, and FedRAMP compliance DNAnexus Apollo™ was designed to seamlessly integrate and analyze diverse datasets, including multi-omic & clinical data, driving actionable insights in real time. DNAnexus Apollo™ is currently powering large-scale geno/pheno projects, including the RGC UK Biobank Consortium Data Delivery — one of the largest population-scale projects containing exome sequencing results and clinical data from 500,000 individuals.

Find us at the talk or schedule a meeting with a member of our team.